You searched for lung cancer | Page 34 of 168

Whole Genome-Based Liquid Biopsy Assay Commercialization, Collaboration Commences

Personalis, Inc. has partnered with Tempus to commercialize NeXT Personal, an ultra-sensitive, whole genome-based liquid biopsy assay.

Posted by Chris Wolski | May 27, 2024 | Lung Cancer |

OncoHost will highlight the PROphet platform’s capability to predict benefits from therapies across various cancers.

Posted by Chris Wolski | May 23, 2024 | Cancer |

Qlucore has released a new version of Qlucore Insights tailored for lung cancer, capable of classifying both primary and metastatic lesions.

Posted by Andy Lundin | May 21, 2024 | Sequencing Systems |

Foundation Medicine launched a tissue-based RNA sequencing test in the U.S. for the detection of cancer-related fusions across 318 genes.

The Karius Test, a diagnostic tool for lung infections in immunocompromised patients, received Breakthrough Device Designation from the FDA.